Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
The Journal of Clinical Investigation
|
March 20, 2020
Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL
Christian Hurtz, Gerald B Wertheim, Joseph P Loftus, et al.
Leukemia
|
December 16, 2024
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia
Tommaso Balestra, Lisa M Niswander, Asen Bagashev, et al.
Haematologica
|
July 1, 2021
Therapeutic potential of ruxolitinib and ponatinib in patients with <i>EPOR</i>-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia
Lisa M Niswander, Joseph P Loftus, Élodie Lainey, et al.
Journal of Veterinary Internal Medicine
|
January 11, 2024
A prospective cohort study to identify clinical diagnostic and prognostic markers of primary immune thrombocytopenia in dogs
Marjory B Brooks, Robert Goggs, Amelia H Frye, et al.
Nature Communications
|
June 1, 2022
Characterisation of a nucleo-adhesome
Adam Byron, Billie G C Griffith, Ana Herrero, et al.
Leukemia
|
July 1, 2021
Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice
Kerri R Thomas, Eric J Allenspach, Nathan D Camp, et al.
Developmental Cell
|
September 26, 2024
An ILK/STAT3 pathway controls glioblastoma stem cell plasticity
Alexander E P Loftus, Marianna S Romano, Anh Nguyen Phuong, et al.
Nature Communications
|
March 24, 2023
Mena regulates nesprin-2 to control actin-nuclear lamina associations, trans-nuclear membrane signalling and gene expression
Frederic Li Mow Chee, Bruno Beernaert, Billie G C Griffith, et al.
Haematologica
|
February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)
Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
Leukemia
|
March 28, 2025
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition
V S S Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
The Journal of Clinical Investigation
|
March 20, 2020
Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL
Christian Hurtz, Gerald B Wertheim, Joseph P Loftus, et al.
Leukemia
|
December 16, 2024
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia
Tommaso Balestra, Lisa M Niswander, Asen Bagashev, et al.
Haematologica
|
July 1, 2021
Therapeutic potential of ruxolitinib and ponatinib in patients with <i>EPOR</i>-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia
Lisa M Niswander, Joseph P Loftus, Élodie Lainey, et al.
Journal of Veterinary Internal Medicine
|
January 11, 2024
A prospective cohort study to identify clinical diagnostic and prognostic markers of primary immune thrombocytopenia in dogs
Marjory B Brooks, Robert Goggs, Amelia H Frye, et al.
Nature Communications
|
June 1, 2022
Characterisation of a nucleo-adhesome
Adam Byron, Billie G C Griffith, Ana Herrero, et al.
Leukemia
|
July 1, 2021
Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice
Kerri R Thomas, Eric J Allenspach, Nathan D Camp, et al.
Developmental Cell
|
September 26, 2024
An ILK/STAT3 pathway controls glioblastoma stem cell plasticity
Alexander E P Loftus, Marianna S Romano, Anh Nguyen Phuong, et al.
Nature Communications
|
March 24, 2023
Mena regulates nesprin-2 to control actin-nuclear lamina associations, trans-nuclear membrane signalling and gene expression
Frederic Li Mow Chee, Bruno Beernaert, Billie G C Griffith, et al.
Haematologica
|
February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)
Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
Leukemia
|
March 28, 2025
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition
V S S Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur, et al.
Page
of 10